Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
Clinical trial NCT00940589 · COMPLETED
Trial details
- NCT number
- NCT00940589
- Sponsor
- Neurim Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.